The periaqueductal gray (PAG) columns have been implicated in controlling stress responses through corticotropin-releasing factor (CRF), which is a neuropeptide with a prominent role in the etiology of fearand anxiety-related psychopathologies. Several studies have investigated the involvement of dorsal PAG (dPAG) CRF mechanisms in models of unconditioned fear. However, less is known about the role of this neurotransmission in the expression of conditioned fear memories in the dPAG and ventrolateral PAG (vlPAG) columns. We assessed the effects of ovine CRF (oCRF 0.25 and 1.0 μg/0.2 μL) locally administered into the dPAG and vlPAG on behavioral (fear-potentiated startle and freezing) and autonomic (arterial pressure and heart rate) responses in rats subjected to contextual fear conditioning. The lower dose injected into the columns promoted proaversive effects, enhanced contextual freezing, increased the blood pressure and heart rate and decreased tail temperature. The lower dose of oCRF into the vlPAG, but not into the dPAG, produced a pronounced enhancement of the fear-potentiated startle response. The results imply that the PAG is a heterogeneous structure that is involved in the coordination of distinct behaviors and autonomic control, suggest PAG involvement in the expression of contextual fear memory as well as implicate the CRF as an important modulator of the neural substrates of fear in the PAG.
Introduction
The neuropeptide corticotropin-releasing factor (CRF) has been implicated in the regulation of the neuroendocrine reaction (Vale et al., 1981) . Over the last decades, CRF has been shown to modulate the autonomic, immunologic, behavioral and cognitive responses to aversive stimuli (Bale and Vale, 2004) . CRF receptors (CRF1 and CRF2) have been demonstrated to be broadly distributed in the structures that compose the limbic circuitry (De Souza et al., 1985; Hauger et al., 2006; Owens and Nemeroff, 1991; Swanson et al., 1983) and experimental evidence demonstrated that intracerebroventricular (i.c.v.) CRF administration increases anxiety-related behavior in rodents (Momose et al., 1999; Yang et al., 2006) . CRF specifically influences the reaction to aversive stimuli when locally injected into structures such as the amygdala (Hubbard et al., 2007; Pitts and Takahashi, 2011) , hippocampus (Pentkowski et al., 2009; Todorovic et al., 2007) , bed nucleus of the stria terminalis (Sink et al., 2012; Walker et al., 2009 ) and periaqueductal gray (PAG) (Borelli and Brandão, 2008; Carvalho-Netto et al., 2007; Martins et al., 1997 Martins et al., , 2000 Miguel and Nunes-de-Souza, 2011) .
The PAG is a limbic structure that is considered to be a final pathway of the stress reaction Carrive, 1993) . Anatomical and histological analyses have divided this structure into longitudinal columns parallel with the aqueduct, including the dorsal (dPAG, comprising dorsomedial and dorsolateral columns), lateral (lPAG) and ventrolateral (vlPAG) columns (Bandler and Shipley, 1994; Carrive, 1993; Keay and Bandler, 2001 ). In rodents, PAG electrical stimulation, lesions or pharmacological manipulation alters anxiety-like behaviors in several paradigms, such as open field (Borelli et al., 2004; Brandão et al., 1999; Coimbra et al., 2006) , elevated plus-maze (Netto and Guimarães, 2004) , conditioned-place aversion (Zanoveli et al., 2007) , contextual conditioned fear Walker and Carrive, 2003) and fear-potentiated startle Zhao et al., 2009) .
Receptor autoradiography and binding studies in different central nervous system regions in the rat demonstrated that there is a substantial population of both CRF receptor subtypes within the different PAG columns (Merchenthaler, 1984; Swanson et al., 1983) . In support of a CRF neurotransmitter role within the PAG columns, the CRF receptor localization corresponds well with the distribution of CRF-immunoreactive terminals in this structure (Steckler and Holsboer, 1999) . Furthermore, perikarya with immunoreactive CRF were identified in the PAG, predominantly in its ventral portion, medial to the Edinger-Westphal nucleus and CRF fibers can also be seen coursing from the amygdala, bed nucleus of the stria terminalis and hypothalamus to the dPAG (Gray and Magnuson, 1992; Swanson et al., 1983) . Also, Bowers et al. (2003) using an electrophysiological recording technique showed that CRF produced a dose dependent excitatory effect on PAG neurons, both in dorsal and in ventrolateral subdivisions.
Ovine CRF (oCRF) and cortagine, a selective CRF1 agonist, administered into dPAG produced anxiogenic-like effects in the mouse defense test battery and rat exposure test, which are animal models used to investigate mice defensive patterns in the presence of natural aversive stimuli (Carvalho-Netto et al., 2007; Litvin et al., 2007) . Additionally, intra-dPAG injection of the CRF antagonist α-helical-CRF reduced anxiety-related behaviors in rodents subjected to the elevated plus-maze (Martins et al., 2000) , whereas oCRF produced opposite responses (Borelli and Brandão, 2008) . Although a number of studies has investigated the involvement of dPAG CRF mechanisms in models of unconditioned fear (Borelli and Brandão, 2008; Carvalho-Netto et al., 2007; Litvin et al., 2007; Miguel and Nunes-de-Souza, 2011) , less is known about the CRF neurotransmission in the expression of conditioned fear memories in the PAG columns. To further investigate this issue, we assessed the effects of CRF locally administered into the dPAG and vlPAG on behavioral (fear-potentiated startle and freezing) and autonomic (arterial pressure and heart rate) responses in rats subjected to contextual fear conditioning. In this paradigm, electrical footshocks are paired with an initially neutral background context. After some pairings, the context evokes a conditioned fear reaction consisting of behavioral and autonomic responses including freezing, urination, increased arterial blood pressure and ultrasonic vocalization (Antoniadis and McDonald, 1999; Bouton and Bolles, 1979; Fanselow and Tighe, 1988; LeDoux et al., 1988; Resstel et al., 2006; Wöhr et al., 2005) .
Materials and methods

Ethics
The experiments reported in this article were performed in accordance with the recommendations of the Brazilian Society of Neuroscience and Behavior and complied with the United States National Institutes of Health Guide for Care and Use of Laboratory Animals. The procedures were approved by the Committee for Animal Care and Use, University of São Paulo (No. 125-2010 and 11.1.308.53.9) . All efforts were made to minimize animal suffering and reduce the number of rats used.
Animals and surgical procedures
A total of 110 male Wistar rats from the animal house of the University of São Paulo Ribeirão Preto campus weighing 220-270 g were used in the study. The rats were housed in groups of four animals per cage with food and water available ad libitum in a temperaturecontrolled room (23 ± 1°C) under a 12 h/12 h light/dark cycle (lights on at 07:00 AM) for 72 h.
Before the experimental sessions, the rats were anesthetized with ketamine/xylazine (100/7.5 mg/kg, intraperitoneal; Agener União, Embu-Guaçu, SP, Brazil) and fixed in a stereotaxic apparatus (David Kopf, Tujunga, CA, USA). The upper incisor bar was set 3.3 mm below the interaural line so that the skull was horizontal between bregma and lambda. After scalp anesthesia with 2% lidocaine, the skull was surgically exposed and a stainless steel guide cannula (10 mm length, 0.6 mm outer diameter, 0.4 mm inner diameter) was unilaterally implanted into the dPAG using lambda as the reference (angle of 16°; coordinates: anterior/posterior, 0 mm; medial/lateral, ±1.9 mm; dorsal/ventral: − 4.1 mm) or vlPAG (angle of 18°; coordinates: anterior/posterior, − 0.2 mm; medial/lateral, ±2.6 mm; dorsal/ventral: − 3.3 mm) according to Paxinos and Watson (2005) . The cannula was fixed to the skull with dental cement and two stainless steel screws. After surgery, the guide cannula was sealed with a stainless steel wire to prevent obstruction, and the rats received an intramuscular injection of penicillin G benzathine (Pentabiotic, 600,000 IU, 0.2 mL; Fort Dodge, Campinas, SP, Brazil) and a subcutaneous injection of the anti-inflammatory and analgesic Banamine (flunixin meglumine, 2.5 mg/kg [10 mg/mL, 0.2 mL]; Schering-Plough, São Paulo, SP, Brazil). After surgery, the rats were returned to their home cages in groups of four and were allowed to recover over a period of five days. To assess autonomic responses, one day prior to the test day, rats were anesthetized with ketamine/xylazine, and a catheter (4 cm PE-10 segment heat-bound to a 13 cm PE-50 segment; Clay Adams, Northridge, CA, USA) was inserted into the abdominal aorta through the femoral artery for cardiovascular recording. The catheter was tunneled under the skin, and exteriorized on the animal's dorsum.
Drug and infusion procedure
Ovine CRF (Sigma-Aldrich) was dissolved in 0.9% physiological saline shortly before use to achieve a final concentration of 0.25 μg or 1 μg/0.2 μL. Physiological saline served as the vehicle control. The drug was administered locally 5 min prior to testing. The doses and times of the injections were based on previous studies (Borelli and Brandão, 2008; Carvalho-Netto et al., 2007) . Infusions were delivered using an infusion pump (Harvard Apparatus, Holliston, MA, USA) in a constant volume of 0.2 μL over 30 s. A thin dental needle (0.3 mm outer diameter) attached by polyethylene tubing to a 5 μL Hamilton syringe was introduced through each guide cannula. The injection needle extended 1.0 mm (dPAG) or 3.0 mm (vlPAG) below the ventral tip of the implanted guide cannula. The displacement of an air bubble inside the polyethylene tubing that connected the syringe to the injection needle was used to monitor the microinjections. The injection needles were left in place for 30 s after the end of the infusion to allow for diffusion.
Fear-potentiated startle test
The acoustic startle reflex is elicited by sudden, unexpected and intense auditory stimulation, and involves a series of rapid and phasic contractions of most of the skeletal muscles throughout the body. The rapidity of the primary response suggests that a relatively simple circuit mediates the startle reflex with few synapses interposed between the auditory nerve and the spinal motoneurons (Koch, 1999; Yeomans et al., 2002) . The fear-potentiated startle paradigm has proven to be useful for analyzing neural systems involved in fear and anxiety. This test measures conditioned fear by an increase in the amplitude of the acoustic startle reflex in the presence of an explicit or contextual cue previously paired with a footshock (Davis et al., 1993; Grillon and Baas, 2003) .
Fifty-eight rats were tested to examine the involvement of the PAG CRF mechanisms in the fear-potentiated startle response in a context previously paired with footshocks. Ovine CRF was injected into the dPAG or vlPAG before the test sessions. The choice of these columns was based on previous data from our laboratory showing that CRF mechanisms in the lPAG did not appear to be involved in the expression of conditioned fear responses (Borelli et al., unpublished data) .
A wire-grid cage (16.5 × 7.5 × 7.5 cm) fixed to a response platform by four thumb screws was used as the test cage. The floor consisted of six stainless steel bars 3.0 mm in diameter spaced 1.5 cm apart. The cage and response platform were located inside a ventilated, soundattenuating plywood chamber (64 × 60 × 40 cm). A loudspeaker located 10 cm behind the test cage delivered both the startle stimulus (100 dB, 50 ms burst of white noise) and continuous background noise (55 dB). The startle reaction of the rats generated pressure on the platform, and the analog signals were amplified, digitized and analyzed using the Startle Reflex software (Med Associates, St. Albans, VT, USA). The startle reaction was recorded within a time window of 100 ms after the onset of the startle stimulus. Calibration procedures were conducted before the experiments to ensure equivalent sensitivities of the response platform.
Matching
For the first 2 days, the rats were placed in the test cage for a 5 min habituation period. Afterwards, the rats received a total of 30 startle stimuli with an interstimulus interval of 30 s. Each matching session lasted 20 min. The rats were assigned to different control and drug groups to achieve similar average startle amplitudes among the groups based on the last matching day. The mean startle amplitude was defined as the baseline condition before training began.
Training
Five days after surgery, the rats were conditioned to the background context in the previously described experimental cage. The rats were placed individually in the cage and received 10 footshocks (0.3 mA, 1 s), after a 5 min acclimation period, with a variable intertrial interval of 60-180 s Reimer et al., 2008) . The footshocks were delivered through the training cage floor by a constant current generator built with a scrambler (Albarsh Instruments; Porto Alegre, RS, Brazil). Stimulus presentation was controlled by a microprocessor and an I/O board (Insight Equipment; Ribeirão Preto, SP, Brazil). Each animal was removed 5 min after the last shock and was returned to its home cage. The duration of each training session was approximately 25 min.
Test
The test sessions were conducted without footshock presentation in the same cage used for matching and training. Twenty-four hours after training, the rats received intra-dPAG or vlPAG injection of oCRF or saline and were placed in the startle test cage after 5 min. After 5 min of habituation, the rats received 30 startle stimuli (noise bursts) with a 30 s interstimulus interval. All the experimental steps were performed in the morning between 8:00 AM and 11:00 AM.
Contextual fear conditioning test
Considerable evidence has shown that rodents acquire fear by exposure to a distinctive environment in which aversive unconditioned stimuli, such as a footshock, had previously been administered. In this situation, the most prominent behavioral outcome is the freezing response (Blanchard and Blanchard, 1969; Kim and Fanselow, 1992; Phillips and LeDoux, 1992; Rudy, 1993) .
Thirty-four rats were used to assess the involvement of CRF-related mechanisms in the PAG in the expression of contextual freezing and autonomic responses. Conditioning and test sessions were conducted in the same chamber (25 × 22 × 22 cm). The side and back walls consisted of gray acrylic and the ceiling and front door consisted of transparent Plexiglas. The grid consisted of 18 stainless steel rods spaced 1.5 cm apart to deliver computer-controlled footshocks (Insight Instruments). The chamber was cleaned with 20% alcohol after each session.
Training
Rats were individually placed in the chamber and received 3 footshocks (0.8 mA, 2 s) after a 3 min acclimation period. The intertrial interval varied randomly between 20 and 60 s (Lisboa et al., 2010) . The rats were removed 3 min after the last shock and were returned to the home cage.
Test
Rats were transferred from the animal room to the test room (distinct from the conditioning room) in their home cage and remained undisturbed for 1 h. Following this adaptation period, the arterial cannula was connected to a pressure transducer, and baseline values of cardiovascular parameters were recorded over 5 min (baseline 1). After injection into the dPAG or vlPAG, autonomic measures were recorded for 5 min while the rats remained in their home cage (baseline 2). The rats were replaced in the footshock chamber, and freezing behavior and autonomic responses were recorded for 10 min. The time of the freezing response was used as the criterion to assess fear conditioning. Freezing was operationally defined as the total absence of movement with the exception of respiration (Bouton and Bolles, 1979) . All of the experiments were monitored in real time by a trained investigator who was unaware of the treatment condition and manually scored the freezing response. The mean arterial pressure (MAP) and heart rate (HR) were recorded using an AECAD 04P amplifier (Solução Integrada Ltda.; São Carlos, SP, Brazil) and an acquisition board (Power lab 8/30; ADInstruments, Colorado Springs, CO, USA) connected to a personal computer. The MAP and HR values were derived from pulse and arterial pressure recordings and were processed online. The cutaneous temperature of the tail was recorded each min using a thermal camera (Multi-Purpose Thermal Imager IRI 4010; Infrared Integrated Systems Ltd., Northampton, UK) at a distance of 50 cm above the tail. The testing was conducted in a room maintained at 26 ± 1°C, which is the thermoneutral zone for rats (Gordon, 1990) . For statistical purposes, the continuous recordings were averaged over 60-s intervals. Changes in the MAP, HR or cutaneous temperature (ΔMAP, ΔHR and ΔTemperature, respectively) were sampled at 1 min intervals. Points sampled during the 5 min period before the exposure were used as control baseline values.
Histology
After the tests, the rats were deeply anesthetized with a lethal dose of chloral hydrate (500 mg/kg, i.p.) and transcardially perfused with 0.9% saline followed by 10% formalin. The brains were removed from the skulls, maintained in formalin solution for 2 h and cryoprotected in 30% sucrose for 72 h. Serial 60 μm brain coronal sections were cut using a cryostat (−19°C), mounted on gelatin-coated slides and stained with cresyl violet (5%, Sigma-Aldrich) to localize the microinjection sites by microscopic examination according to the atlas of Paxinos and Watson (2005) . Eighteen rats were excluded from the analysis because of inappropriate cannula placement.
Statistical analysis
The software used for all statistical analyses was STATISTICA version 6.0. The data are expressed as mean ± standard error of the mean (s.e.m.). Two-way analysis of variance (ANOVA) with repeated measures was used to assess the effects of oCRF injections into the dPAG or vlPAG on the startle amplitude with treatments (drug and saline) and conditions (baseline and test) as factors. Time of freezing was analyzed using one-way ANOVA. Significant comparisons were further evaluated using the Newman-Keuls post-hoc test. The baseline values of the MAP, HR and cutaneous temperature recorded before chamber reexposure were compared using one-way ANOVA. The MAP, HR and cutaneous temperature measured during the test were analyzed using two-way ANOVA with treatment as the main independent factor and time as the repeated measurement. Post-hoc comparisons were performed with t-tests and a Bonferroni adjustment. In all cases, values of p b 0.05 were considered statistically significant.
Results
Representative photomicrographs of microinjections into the dPAG and vlPAG and diagrammatic representations of the saline and oCRF injection sites in these areas are shown in Fig. 1 .
Effect of intra-PAG oCRF on fear-potentiated startle test
A timeline of the procedures for testing the involvement of CRF mechanisms in the expression of the fear-potentiated startle is depicted in Fig. 2 (A) . The mean startle amplitude for rats receiving intra-dPAG saline (n = 10), oCRF 0.25 μg (n = 9), or oCRF 1.0 μg (n = 9) before the testing session is shown in Fig. 2 (B) . Two-way ANOVA revealed statistically significant effects of the conditions (F1,25 = 33.76, p b 0.01) but not of the treatments (F2,25 = 0.39, p > 0.05) or the treatments vs. conditions interaction (F2,25 = 0.93, p > 0.05). The NewmanKeuls post-hoc test revealed that reexposure to the environment in which footshocks were previously administered enhanced the startle response in all the groups. The mean startle amplitude for the rats receiving intra-vlPAG saline (n = 11), oCRF 0.25 μg (n = 10), or oCRF 1.0 μg (n = 9) before the testing session is illustrated in Fig. 2  (C) . Two-way ANOVA revealed statistically significant effects of the conditions (F1,27 = 47.78, p b 0.05), treatments (F2,27 = 3.18, p b 0.05) and the treatments vs. conditions interaction (F2,27 = 5.01, p b 0.05).
The Newman-Keuls post-hoc test revealed that reexposure to the environment in which footshocks were previously administered enhanced the startle response in all the groups. However, the conditioned startle reflex was higher in the group treated with oCRF 0.25 μg compared with the control group.
Effect of intra-PAG CRF on the contextual fear conditioning test
A timeline of the procedure for testing the effects of the oCRF injection into the PAG columns in the expression of contextual freezing behavior and autonomic responses is depicted in Fig. 3 (A) . The mean freezing time exhibited for rats receiving intra-dPAG saline (n = 6), oCRF 0.25 μg, or oCRF 1.0 μg (n = 5 each dose) before exposure to the environment in which footshocks were previously administered is illustrated in Fig. 3 (B) . One-way ANOVA showed that the treatment produced statistically significant effect (F2,15 = 14.99, p b 0.01). Post-hoc tests revealed that oCRF 0.25 μg increased the expression of conditioned contextual freezing compared with the saline-treated rats. The mean freezing time exhibited for rats receiving intra-vlPAG saline, oCRF 0.25 μg, or oCRF 1.0 μg (n = 6 in each group) before exposure to the environment in which footshocks were previously administered is shown in Fig. 3 (C) . One-way ANOVA revealed that the treatment produced statistically significant effect (F2,17 = 144.90, p b 0.01). The post-hoc test showed that oCRF 0.25 μg increased the expression of conditioned contextual freezing compared with the control group.
Effect of intra-PAG CRF on autonomic measures
The autonomic responses evaluated in this study are depicted in Figs 
Discussion
To assess the involvement of intra-PAG CRFergic mechanisms in the behavioral (fear-potentiated startle and freezing) and autonomic (MAP, HR and tail temperature) expression of fear conditioning, oCRF was injected into the dPAG and vlPAG of rats before exposure to an environment in which footshocks were previously administered. Although intra-dPAG oCRF did not alter the startle response exhibited by rats exposed to contextual fear, the lower dose promoted a proaversive effect, which enhanced contextual freezing, blood pressure and heart rate and decreased the tail temperature. These findings are consistent with previous studies demonstrating that intra-dPAG oCRF increased unconditioned anxiety-like responses in the EPM (Borelli and Brandão, 2008) and intra-dPAG administration of the CRF antagonist α-helical-CRF reduced anxiety-related behaviors in stress-experienced rats (Martins et al., 2000) .
The increased contextual freezing and autonomic responses caused by the lower dose of the drug indicate that the lack of effect on fear-potentiated startle was not an artifact of improper dosage. Moreover, the role of CRF mechanisms in the startle response is not clear (de Jongh et al., 2003; Schulz et al., 1996; Swerdlow et al., 1989 ) and appears to depend on a number of factors, including the stimulated region (Bijlsma et al., 2011; Walker et al., 2009; Zhao et al., 2009) , functional integrity of brain structures (Antoniadis et al., 2009; Fendt et al., 1994; Lee and Davis, 1997) , participation and interaction with other neurochemical systems (Boyson et al., 2011; Conti, 2012; Gresack and Risbrough, 2011) and involvement of distinct CRF receptors (Risbrough et al., 2003 (Risbrough et al., , 2004 (Risbrough et al., , 2009 . Based on the distinct effects of oCRF injection into the dPAG on conditioned freezing and fear-potentiated startle, different neurochemical mechanisms and neural circuitries could mediate the fear responses generated in these two tests de Oliveira et al., 2012; Reimer et al., 2012) . The dorsal regions of the PAG may be involved in the expression of unconditioned and/or avoidance behaviors, whereas conditioned responses may recruit the ventral parts of this mesencephalic structure. We previously demonstrated that intra-dmPAG injection of oCRF increased risk assessment behaviors in rats subjected to the EPM test ( Borelli and Brandão, 2008) . This class of behavior has been proposed to reflect information-gathering processes triggered in potentially threatening situations, which optimizes the best adaptive behavioral strategy (Albrechet-Souza et al., 2009; Blanchard et al., 1993) .
In contrast to the dPAG, rats that received intra-vlPAG injections of oCRF at the lower dose before the test session exhibited increased fear-potentiation startle. The same dose also increased the contextual freezing response, blood pressure and heart rate and decreased the tail temperature, which indicates proaversive effects of CRF in emotional circuitry areas (Griebel, 1999; Owens and Nemeroff, 1991; Yang et al., 2006) . These results suggest that endogenous CRF systems in the PAG columns may have a role in modulating behavioral and autonomic Percentage of freezing time response in rats receiving intra-dPAG (B) or vlPAG (C) injection of 0.2 μL of saline, oCRF 0.25 μg, or oCRF 1.0 μg/0.2 μL subjected to contextual fear. Time-course of microinjection of saline or oCRF at doses of 0.25 μg or 1.0 μg/0.2 μL into the dPAG (left column) or vlPAG (right column) on mean arterial pressure (MAP; D and E), heart rate (HR; F and G) and cutaneous temperature (H and I) of rats exposure to the environment in which footshocks were previously administered. Results are expressed as means ± s.e.m. *p ≤ 0.05 compared with the control group. responses to stress. The results also support the specificity of PAG columnar modulation of aversive responses once CRF seems to present a distinct action in the dPAG and vlPAG. Thus, different neural circuits could be recruited at the PAG level during the expression of the contextual freezing and the production of fear-potentiated startle mediated by the CRF system.
Our findings show that, compared with dPAG, vlPAG CRF-related mechanisms are involved on the expression of distinct conditioned fear responses. CRF immunoreactive terminals in the PAG originate from the amygdala, bed nucleus of the stria terminalis and hypothalamus (Gray and Magnuson, 1992) . High-density CRF-immunoreactive neurons are located in the amygdaloid complex and the basolateral nucleus of the amygdala is well-established to be involved with the CS-US association (Pitts and Takahashi, 2011) . Thus, fear expression appears to originate from basolateral nucleus projections crossing through the central nucleus of the amygdala to the bed nucleus of the stria terminalis (Dong et al., 2001 ) and projecting into the vlPAG (Dong and Swanson, 2004) , which is directly involved in the expression of the conditioned fear responses (LeDoux et al., 1988; Walker and Carrive, 2003) .
Considering the effects of oCRF on autonomic measurements our results indicated that activation of CRF receptors in the PAG columns (dPAG and vlPAG) are involved in the mediation of autonomic response to stress. In fact, the PAG contains the neural substrate required to recruit the sympathetic nervous system and organizes physiological and behavioral responses required to respond to environmental challenges (Dean, 2011; Lovick, 1985) . A prior study showed that CRF i.c.v. administration elicits cardiovascular responses similar to the effects of stress by increasing heart rate, cardiac output and mean arterial pressure, responses mediated by an intact sympathetic nervous system (Fisher et al., 1983) . Morimoto et al. (1993) clearly demonstrated that during stress responses, central CRF modulates anxiety-related cardiovascular responses, altered body temperature and altered locomotor activity. These responses were significantly attenuated by pretreatment with i.c.v. injection of the CRF antagonist a-helical CRF (9-41), although significant changes were not induced in unstressed rats. Interestingly, oCRF injected into the dPAG and vlPAG did not alter autonomic measurements in rats before exposure to the aversive context, indicating the specific involvement of this peptide in modulating the responses elicited by the PAG during the stress response. Thus, it is likely that CRF mechanisms in the PAG do not mediate cardiovascular responses and body temperature regulation during the resting state in a nonstressful environment.
In this study, however, oCRF injected into the dPAG or vlPAG at higher doses did not induce behavioral or autonomic changes, and some possibilities can be considered to explain these results. A reasonable possibility could be that oCRF, at higher doses, may nonspecifically act on both CRF1 and CRF2 receptors, clearly supporting the notion of opposed information processing mechanisms of these receptors during the stress (Bakshi and Kalin, 2000; Koob and Heinrichs, 1999; Reul and Holsboer, 2002) . Indeed, some evidence indicates that anxiety-like behaviors mediated by CRF1 activation are reduced when CRF2 receptors are activated (Bale et al., 2000; Kishimoto et al., 2000) . Alternatively, this absence of effects may be associated to an "inverted U" doseresponse mechanism, often observed for a wide variety of neuropeptides (McGaugh, 1983; Price and Cooper, 1975 ). These phenomena encompass every level of biological organization from gene expression, hormone production and cell number to changes in tissue architecture (for review see Vandenberg et al., 2012) .
Altogether, our findings corroborate the previous idea of the PAG as a heterogeneous structure involved in the coordination of distinct behaviors and autonomic control Rea et al., 2011; Vieira et al., 2011) and further indicate the participation of PAG CRF mechanisms in stress responses exhibited in threatening environments. Indeed, some anxiety disorders have been linked to abnormalities in CRF signaling. Patients with post-traumatic stress disorder exhibit elevated levels of CRF in the cerebrospinal fluid (de Kloet et al., 2008; Sautter et al., 2003) . Mutations in CRF (Smoller et al., 2005) and the CRF1 receptor genes (Keck et al., 2008) have been associated with traits predictive for panic disorder and panic disorder diagnoses, respectively. Thus, identifying CRF receptor signaling pathways that mediate defensive responses is crucial to extend our understanding of the neural basis of physiological fear, as well as associated disorders.
